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Summary
Accumulating evidence demonstrates the intimate
association between human hosts and the gut micro-
biome. Starting at birth, the sterile gut of the newborn
acquires a diverse spectrum of microbes, needed for
immunological priming. However, current practices
(caesarean sections, use of formula milk) deprive
newborns from being exposed to this broad spectrum
of microbes. Unnecessary use of antibiotics and
excessive hygienic precautions (e.g. natural versus
chlorinated drinking water) together with the Western
diet further contribute to a decreased microbial diver-
sity in the adult gut. This has been correlated with
recurrent Clostridium difficile infection, inflammatory
bowel diseases and obesity, among others. A healthy
gut microbiome is thus characterized by a diverse
network of metabolically interacting microbial
members. In this context, we review several existing
and novel approaches to manage the gut microbiome.
First, prebiotic compounds should be re-defined in
the sense that they should enhance the ecological
biodiversity rather than stimulating single species.
Recent studies highlight that structurally different
polysaccharides require specific primary degraders
but also enhance a similar network of secondary
degraders that benefit from cross-feeding. A faecal
transplantation is a second approach to restore
biodiversity when the microbiota is severely dysbi-
osed, with promising results regarding C. difficile-
associated disease and obesity-related metabolic
syndromes. A final strategy is the introduction of key
microbial network units, i.e. pre-organized microbial
associations, which strengthen the overall microbial
network of the gut microbiome that supports human
health.
Introduction
Over the last decades, specific mechanisms of how the
human gut microbiome determines human health or
disease states have been elucidated (Round and
Mazmanian, 2009). It has become clear that the dynamic
interaction with these intestinal microbes can be divided in
different stages over the human lifespan (Fig. 1). Drastic
changes occur during the first years of life as the newborn
gut progresses from a sterile environment to a densely
populated microbial habitat. This gut ecosystem exerts
restrictive selection on its microbial inhabitants as only
microbes that are capable of establishing a mutualistic
relation with the host are maintained (Backhed et al.,
2005; Ley et al., 2008). In human infancy and early child-
hood, the complex microbial ecosystem is formed through
the successive establishment of different bacterial groups;
aerotolerant bacteria establish first, followed by more and
more strict anaerobes, as observed in ex-germfree reduc-
tionist animal models (Adlerberth and Wold, 2009). As a
result, the infant gastrointestinal microbiota is quite vari-
able in its composition and relatively unstable over time.
On average, 3 years after birth the microbial community
consists of a mixture of microbes that is largely similar to
that found in the adult intestine (Yatsunenko et al., 2012).
At that time, the complex microbiota is predominantly
colonized by obligate anaerobes to provide a strong
barrier against the establishment and proliferation of new
bacterial groups, in a phenomena known as colonization
resistance (Vollaard and Clasener, 1994). The colonizing
microbes can rapidly shape themselves in response to
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changes in host environment. Likewise, when the host
environment changes, the immune system and metabolic
profile must adjust to these fluctuations in order to keep a
mutualistic relationship with its microbiota. Although
individual-specific and relatively stable in younger healthy
adults, the microbiota in elderly displays greater inter-
individual variation (Claesson et al., 2011). Such high
variation correlates with immunosenescence, which char-
acterizes the ageing process (Claesson et al., 2012).
Moreover, once its symbiotic coexistence is disrupted
during acute (e.g. invasion of pathogens or antibiotic treat-
ment) or chronic conditions (e.g. inflammatory bowel dis-
eases and obesity), the microbial community may become
a major threat to the host.
This raises the question of how to restore the microbial
dysbiosis and the resulting imbalance in the host–microbe
symbiotic relationship when things go wrong. Existing
approaches to manage the human gut microbiome
include functional foods such as probiotics, prebiotics and
synbiotics. While probiotics are beneficial live microorgan-
isms (FAO/WHO, 2002), prebiotics are indigestible food
compounds that selectively stimulate specific beneficial
microbial genus(era)/species already present in the gut
(Gibson and Roberfroid, 1995; Roberfroid et al., 2010).
Unfortunately, antibiotics are still commonly prescribed
causing severe disturbances in the microbiome. A very
promising therapeutic approach is the use of faecal trans-
plants, which allows to install a healthy, diverse gut micro-
biome in a human subject that suffered from a severely
dysbiosed gut microbiota. In this mini-review, we empha-
size the importance of biodiversity and, in this context,
re-define the current prebiotic concept. We also propose a
novel ecosystem-based approaches to restore host–
microbial imbalances in disease based on the success of
faecal transplants, i.e. by providing specific microbial
network units.
The biodiversity concept
Biodiversity is generally considered crucial for the well-
functioning of an ecosystem. This is also valid for the
microbial ecosystem of the human gut where a decreased
diversity has been correlated with disease states such
as recurrent Clostridium difficile infection (Chang et al.,
2008), Crohn’s disease (Manichanh et al., 2006) and
obesity (Turnbaugh et al., 2009). A recent study by
Yatsunenko and colleagues (2012) elucidated that US
residents have a markedly less diverse microbiota than
human subjects living in ancient geographic locations.
This lower microbial diversity is caused by several
typical Western society practices. Everything starts at
birth, as caesarean sections are becoming a common
mode of delivery. In 2010, almost one-third of the births in
the USA was through caesarean delivery (Martin et al.,
2012). This deprives the newborn from being exposed to
a broad spectrum of vaginal microbes resulting in lower
intestinal microbial diversity in the gut microbiome of the
newborn (Biasucci et al., 2008). Moreover, breastfeeding
is often replaced by formula milk despite the fact that
breast milk is essential for the early microbial develop-
ment by providing nutrients for early-life symbionts (e.g.
bifidobacteria) (Sela and Mills, 2010) and even by provid-
ing live bacteria (Cabrera-Rubio et al., 2012). Misuse of
antibiotic treatments (Dethlefsen et al., 2008) further con-
tributes to the decreased microbial diversity in the human
gut microbiome. Another microbial exposure route that
has been decreasing in the last decades is exposure via
the drinking water. In most countries, drinking water is
sterilized by the addition of chlorine. In countries such as
the Netherlands and Switzerland water is not disinfected.
Although drinking water may not contain real gut com-
mensals, drinking chlorinated water instead of non-
disinfected water raises questions regarding immune
system education capacity. The question is often raised
whether public health, fitness or capacity to excel might
relate to the issue of natural versus chlorinated water, but
is still not documented properly. This issue certainly
deserves appropriate study.
The Western diet that is unbalanced and too homoge-
neous in composition also contributes to a lower microbial
diversity and eventually does not support the co-evolved
host–microbe partnership (De Filippo et al., 2010). The
non-digestible fraction consists of substrates that do not
require complex metabolic interactions between members
of the gut microbial ecosystem. This results in rapid
release of nutritional energy by a limited amount of
microbes. In contrast, diets that have a high dietary fibre
content do support microbial diversity as this stimulates
microbial interactions through which nutrient-derived
energy is harvested in different stages by different micro-
bial members. This can be compared with the dissipation
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Fig. 1. Changes in the gut microbiome over the course of a human
lifespan. After drastic changes in early childhood, the gut microbiota
stabilizes to an adult microbial composition. During the elderly and
acute or chronic diseases, specific states of dysbiosis have been
documented. Future ecosystem approaches to restore intestinal
imbalances may thus target four distinct populations (A: newborns;
B: young adults; C: diseased subjects; D: elderly).
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of potential energy over several meanders in a river
system. We therefore state that a healthy well-structured
microbiome is characterized by a meandering metabolism
(Fig. 2). Such slow release of nutritional energy is char-
acteristic for high fibre diets which may protect against
inflammation and non-infectious colonic diseases (De
Filippo et al., 2010). In contrast, the typical Western diet
results in dissipation of the nutrient-derived energy
through shortcuts in such metabolic meanders. In terms of
the ecological r/K-selection theory (Pianka, 1970), this
selects for a higher abundance of r-strategists: microor-
ganisms that have a low substrate affinity but that display
high growth rates when easily degradable substrates are
abundantly available. This also results in a depletion of
K-strategists: microorganisms that have a high substrate
affinity but that display low growth rates as they rely on
other microbial members that participate in the metabolic
‘meandering’ network.
Starting at birth, the human body is exposed to a lower
diversity of microbial antigens as a consequence of the
reported typical Western society practices. This results in
a weakened immune regulation that depletes the gut
mucosal barrier and predisposes the human host to
Western diseases that have been increasing since the
beginning of the 20th century.
Towards ecosystem approaches to restore the
diversity of the human microbiome: prebiotics,
faecal transplants and microbial network units
Given the importance of biodiversity in the gut microbiome
for human health, therapeutic strategies that aim at
improving health should incorporate this biodiversity
concept. Besides redefining existing concepts such
as the prebiotic concept, this may lead to novel
ecosystem-based approaches such as supplementation
of essential microbial network units.
First, the concept of prebiotic compounds may need to
be revised. Prebiotics have been defined as ‘indigestible
food compounds that selectively stimulate the growth
and/or activity of one or a limited number of microbial
genus(era)/species in the gut that confer(s) health ben-
efits to the host’ (Gibson and Roberfroid, 1995; Roberfroid
et al., 2010). While stimulation of bifidobacteria or lacto-
bacilli is generally regarded as beneficial, this concept
seems too narrow. A new, more accurate definition for a
prebiotic compound may be ‘an indigestible food com-
pound that stimulates the ecological biodiversity in the
human gut microbiome’. Indeed, a recent study using a
novel molecular tool with high-phylogenetic resolution
indicated that prebiotic compounds such as inulin (IN) and
long-chain arabinoxylans (LC-AX) both increase the
abundance of specific primary degraders. Despite the
very different structure of IN and LC-AX, both compounds
also increased a similar spectrum of secondary degraders
that benefit through cross-feeding with the primary
degrader (Table 1) (Van den Abbeele et al., 2011). Such
microbes that increased in both treatments mostly
belonged to relatives from the Clostridium clusters IV and
XIVa. Although primary degraders are essential to initiate
the breakdown of the specific polysaccharides, the stimu-
lation of these microbial networks/meanders increases
the microbial diversity and may be more beneficial than
the increase of a specific primary degrader.
A second approach to restore microbial diversity when
a human microbiota is severely disturbed is a faecal trans-
plantation (Shahinas et al., 2012). This approach has
already been applied to treat C. difficile-associated
disease (Khoruts et al., 2010; Guo et al., 2012), which is
thought to result from persistent disruption of the
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Fig. 2. The stepwise release of
carbohydrate-derived energy by gut microor-
ganisms can be compared by a meandering
river in which the water potential energy is
gradually lowered. Such an environment
creates many functional niches thereby
selecting for a high microbial diversity,
similar to a high biological diversity in mean-
dering river ecosystem. Shortcuts through
microbial metabolic meanders in the human
gut can be compared with the canalization
of a meandering river. Such environment
entails a limited amount of functional niches
thereby selecting for a limited microbial
diversity.
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commensal gut microbiota and which is considered as an
important cause of antibiotic-induced diarrhoea and
colitis. Moreover, faecal transplantation from lean indi-
viduals to individuals suffering from metabolic syndrome,
displayed increased insulin sensitivity corresponding with
stimulation of microbial groups that are known to benefit
from cross-feeding (metabolic meandering) such as
butyrate-producing microbes of the Clostridium clusters IV
and XIVa (Vrieze et al., 2012). Faecal transplants thus
seem to be promising techniques to restore microbial
diversity in microbial communities that are severely dys-
biosed. However, given the high microbial complexity of
human faeces, faecal samples require thorough risk
assessment before they can be applied as a faecal trans-
plant. Therefore, faecal transplants are only applied in
severe cases while otherwise antibiotics are still a
common practice. To guarantee a more stable and diverse
microbial composition during such antibiotic treatments,
the current recommendation is to consume yoghourt or
cheese (often containing a single microbial species)
during these treatments. The current state of the art
should allow to go beyond these recommendations and
design much better products.
Therefore, based on the concept of faecal transplants,
we introduce a third concept to remediate a dysbiosed
microbiota or to assist microbiome development during
different stages of a human lifespan: intestinal microbial
network units. Such a network unit contains a consortium
of microbes that is capable of performing a specific func-
tion, as we will demonstrate according to three different
examples: degradation of specific complex polysaccha-
rides (e.g. starch, LC-AX or mucins), induction of specific
immune pathways (e.g. Treg cells) or a mixture of essen-
tial symbionts for a specific human life stage (e.g. micro-
bial mix for newborns).
The first example considers the fermentation of other-
wise indigestible polysaccharides to health-promoting
short-chain fatty acids. This microbial metabolic function
is so beneficial that it is assumed to be the main evolu-
tionary driving force to include microorganisms in the
gastrointestinal tract and to acquire carefully designed
defence mechanisms (McFall-Ngai, 2007). The diverse
spectrum of glycans, which is present in the human colon,
is derived from the diet (resistant starch, LC-AX, IN) or the
host (mucins). To construct a microbial network unit for
these specific glycans, one needs to consider the concept
of a king and his court. First, there is the specific primary
degrader or keystone species for this glycan (‘king’). For
many of the diverse spectrum of glycans that are present
in the colon, such keystone species have been proposed.
As an example, resistant starch requires the presence of
Ruminococcus bromii (Ze et al., 2012), LC-AX are spe-
cifically degraded by Bifidobacterium longum (Van den
Abbeele et al., 2011) and Akkermansia muciniphila seems
a crucial species for the initial breakdown of mucins
(Belzer and de Vos, 2012). To produce an industrial
product, i.e. an effective microbial network unit, one also
needs to provide the primary degrader (‘king’) with its
cross-feeding microbes (‘court’). This may be achieved
using conventional in vitro fermentors which can be inocu-
lated with relevant keystone species and a mixture of
cross-feeding microbes (e.g. relatives of the microbial
groups listed in Table 1). After inoculation and stabiliza-
tion, such a microbial network unit for specific functions
can be attained and produced at large scale.
As a second example, microbial network units may also
be constructed for specific immunomodulatory functions
such as induction of the regulatory arm of colonic T cells.
A recent study by El Aidy and colleagues (2012a) reported
on the dynamic changes in the regulation of intestinal
homeostasis during microbial colonization. During the
process of microbial colonization in germfree mice, inflam-
matory tissue responses were avoided by the induction of
the regulatory arm of T cells, including (among others)
Foxp3 and Il10 markers for tolerance-promoting Tregs
that were induced, especially during the later stage of
colonization of the colon. The expression of these toler-
ance markers paralleled the colonization of several
Table 1. Complex polysaccharides that arrive in the colon [such as long-chain arabinoxylans (LC-AX) or inulin (IN)] increase the abundance of
specific primary degraders but importantly, they also increase a similar cohort of secondary degraders that benefit through cross-feeding. This
increases the microbial diversity of the human microbiome.
Higher taxonomic group Bacterial group
Percentual abundance (%)
Control LC-AX IN
Clostridium cluster IV Subdoligranulum variable-like 0.50  0.06a 1.44  0.37b 1.59  0.29b
Clostridium cluster XIVa Clostridium colinum-like 0.62  0.04a 3.20  0.10b 3.65  0.37b
Clostridium sphenoides-like 1.63  0.27a 3.36  0.17b 3.23  0.21b
Eubacterium rectale-like 0.96  0.16a 4.72  0.36b 5.95  0.69b
Lachnospira pectinoschiza-like 0.98  0.11a 2.54  0.18b 3.16  0.19c
Lachnobacillus bovis-like 1.06  0.21a 2.72  0.60ab 3.11  0.47b
Roseburia intestinalis-like 0.54  0.05a 4.43  1.10b 5.90  1.11b
This table contains an example of such a cohort of secondary degraders, as identified during a study with humanized rats, treated with LC-AX or
IN Van den Abbeele et al., 2011). The abundance (%) of bacterial groups (belonging to higher taxonomic groups) are based on the HITChip
analysis. Values indicated with a different superscript are significantly different (a, b or c; n = 4).
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Clostridium cluster IV and XIVa species (El Aidy et al.,
2012b). The latter bacterial groups were previously
reported to stimulate the expression of Tregs (Atarashi
et al., 2011), potentially related to their strong capacity to
colonize the mucin-associated microbiota (Van den
Abbeele et al., 2012). Moreover, these Clostridium cluster
IV and XIVa species represent only a small proportion
of the microbial community in the inflammatory bowel
disease patients (Frank et al., 2007). Constructing a
microbial network unit that contains these species may
thus allow reaching a microbial network unit that specifi-
cally induces colonic Tregs that may be relevant for
administration to inflammatory bowel disease patients.
Third, microbial network units may also be relevant with
respect to the different stages of a human lifespan (Fig. 1).
As discussed above, current Western society practices
such as caesarean sections and the use of formula milk,
contribute to early host–microbial imbalances. When
designing a microbial mix for babies, it will be important
that besides the presence of well-known early-life symbi-
onts such as Bifidobacterium sp., also bacteria perceived
as rather harmful should be administered (probably after
sterilization). This was pointed out by a recent study of Mai
and colleagues (2011) who investigated the early micro-
bial factors that may cause necrotizing enterocolitis in
preterm infants. The latter study is unique in its experimen-
tal set-up, as samples were collected before disease,
rather than collecting samples when babies are already ill.
Necrotizing enterocolitis went along with a bloom in the
Proteobacteria but importantly the disease was preceded
by lower-than-normal levels of Proteobacteria in the early
microbial population of these babies. For a proper immune
maturation, both beneficial and detrimental microbes are
thus necessary. Similarly, microbial network units may be
designed for 3-year-old children that should be colonized
by an adult-like microbiota, while also the elderly may
profit from a specific microbial consortium.
Finally, microbes that may be beneficial for the entire
human population may be administered to the drinking
water. Recently, there were already trials to apply ‘Effec-
tive Microorganisms (EM)’ in water treatment as well as in
other domains including agriculture and supplements for
human consumption (Daiss et al., 2008; Ke et al., 2009).
EM are mixed cultures of beneficial natural fermentative
microorganisms that can be applied to increase the nec-
essary microbial diversity needed for living. EM consist of
a mixed culture of photosynthetic bacteria, lactic acid
bacteria and yeast. While further research is still required
to unravel the health consequences of consumption of
disinfected versus undisinfected naturally colonized
water, people consuming water treated with EM will pre-
sumably gain the benefit of the metabolites developed by
these microorganisms, which act as substrates for
increasing beneficial populations.
Conclusions
Past and ongoing research has allowed to appreciate the
importance of biodiversity in the human gut microbiome,
caused by the diverse metabolic interactions among dif-
ferent microbial species. Rather than stimulating single
species, prebiotic compounds should enhance these
metabolic interactions to support a biodiverse gut micro-
biome. Based on the already elucidated important micro-
bial processes within the complex human gut microbiome,
future research should further aim at the elucidation and
the technical formulation, production and validation of
specific microbial network units.
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